- EPIC-STI BIOSTATISTICS AND BIOINFORMATICS CORE (BBC) (CUZICK/WHEELER) The Biostatistics and Bioinformatics Core (BBC) provides support with design, data management and analysis of research studies for the Epidemiology Prevention Interdisciplinary Center for Sexually Transmitted Infections (EPIC-STI). Moreover, it serves as a centralized resource for biostatistical consulting, methods development and analyses for scientific projects. The unit provides a centralized analytic base to each of the four scientific projects as well as new pilot developmental research projects at all levels of investigation, beginning with the formulation of more specific hypotheses related to the overall unifying hypotheses, reviewing study designs, and evaluating the utility of measurement techniques. Support and consultation concludes with aiding in the interpretation, presentation, and final writing of results. The EPIC-STI BBC also serves to warehouse and maintain a public health population-based data resource, the New Mexico HPV Pap Registry (NMHPVPR), a cornerstone of the overall EPIC-STI and a model of integrated health informatics. The BBC will promote the EPIC-STI research aims as follows: 1) finalize the study designs and protocols in collaboration with each study investigator;2) mentor, train and foster exchange programs for junior investigators transitioning toward careers in STI research;3) collaborate with the study investigators in the development of data collection instruments and applications;3) assist in development of protocols for secure data transmission;4) collaborate with the study investigators in developing detailed study manuals;5) develop and manage the EPIC-STI central and project-specific relational databases including the NMHPVPR;6) run SAS quality-control program checks;7) maintain a Master Database for each project with appropriate backups and security checks;8) monitor study progress and distribute quarterly reports;9) produce reports summarizing data acquisition by subject, distributions and summary statistics for the primary variables;10) interface and perform linkages to the New Mexico state-wide immunization information system (NM-SIIS) and other administrative and statistics data sources;11) perform basic, complex and exploratory statistical analyses;12) develop new methods for analysis of complex datasets;and 13) develop and maintain the EPIC-STI web site and portals.

Public Health Relevance

- EPIC-STI BIOSTATISTICS AND BIOINFORMATICS CORE (BBC) (CUZICK/WHEELER) The Epidemiology and Prevention Interdisciplinary Center for Sexually Transmitted Infections (EPIC-STI) focuses on the most common STI agents, human papillomavirus (HPV) and Chlamydia trachomatis (CT). To maximally realize improvements in HPV and CT prevention, basic biological discovery, technology and methodologic advances, molecular epidemiology and population effectiveness is partnered across laboratory, clinical &real-world setting.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI113187-01
Application #
8769912
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
1
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of New Mexico Health Sciences Center
Department
Type
DUNS #
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Jiang, Rosie T; Schellenbacher, Christina; Chackerian, Bryce et al. (2016) Progress and prospects for L2-based human papillomavirus vaccines. Expert Rev Vaccines 15:853-62
Gravitt, Patti E (2016) HPV Seroprevalence in the United States: Behavior, Biology, and Prevention. J Infect Dis 213:171-2
Benard, Vicki B; Castle, Philip E; Jenison, Steven A et al. (2016) Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era. JAMA Oncol :
Saboo, Sugandha; Tumban, Ebenezer; Peabody, Julianne et al. (2016) Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus. Mol Pharm 13:1646-55
Mirrashidi, Kathleen M; Elwell, Cherilyn A; Verschueren, Erik et al. (2015) Global Mapping of the Inc-Human Interactome Reveals that Retromer Restricts Chlamydia Infection. Cell Host Microbe 18:109-21
Zhang, Xuqing; Starnbach, Michael N (2015) An Excess of the Proinflammatory Cytokines IFN-γ and IL-12 Impairs the Development of the Memory CD8+ T Cell Response to Chlamydia trachomatis. J Immunol 195:1665-75
Nogueira, Catarina V; Zhang, Xuqing; Giovannone, Nicholas et al. (2015) Protective immunity against Chlamydia trachomatis can engage both CD4+ and CD8+ T cells and bridge the respiratory and genital mucosae. J Immunol 194:2319-29
Stary, Georg; Olive, Andrew; Radovic-Moreno, Aleksandar F et al. (2015) VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science 348:aaa8205
Tumban, Ebenezer; Muttil, Pavan; Escobar, Carolina Andrea A et al. (2015) Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2. Vaccine 33:3346-53